BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Rossi S, Motta C, Studer V, Macchiarulo G, Volpe E, Barbieri F, Ruocco G, Buttari F, Finardi A, Mancino R, Weiss S, Battistini L, Martino G, Furlan R, Drulovic J, Centonze D. Interleukin-1β causes excitotoxic neurodegeneration and multiple sclerosis disease progression by activating the apoptotic protein p53. Mol Neurodegener 2014;9:56. [PMID: 25495224 DOI: 10.1186/1750-1326-9-56] [Cited by in Crossref: 56] [Cited by in F6Publishing: 59] [Article Influence: 7.0] [Reference Citation Analysis]
Number Citing Articles
1 Gruchot J, Lein F, Lewen I, Reiche L, Weyers V, Petzsch P, Göttle P, Köhrer K, Hartung H, Küry P, Kremer D. Siponimod Modulates the Reaction of Microglial Cells to Pro-Inflammatory Stimulation. IJMS 2022;23:13278. [DOI: 10.3390/ijms232113278] [Reference Citation Analysis]
2 Gusev E, Zhuravleva Y. Inflammation: A New Look at an Old Problem. Int J Mol Sci 2022;23:4596. [PMID: 35562986 DOI: 10.3390/ijms23094596] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
3 Perdaens O, van Pesch V. Molecular Mechanisms of Immunosenescene and Inflammaging: Relevance to the Immunopathogenesis and Treatment of Multiple Sclerosis. Front Neurol 2022;12:811518. [DOI: 10.3389/fneur.2021.811518] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
4 Sánchez-Fernández A, Zandee S, Mastrogiovanni M, Charabati M, Rubbo H, Prat A, López-Vales R. Administration of Maresin-1 ameliorates the physiopathology of experimental autoimmune encephalomyelitis. J Neuroinflammation 2022;19:27. [PMID: 35109863 DOI: 10.1186/s12974-022-02386-1] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
5 Lauro F, Giancotti LA, Kolar G, Harada CM, Harmon TA, Garrett TJ, Salvemini D. Role of Adenosine Kinase in Sphingosine-1-Phosphate Receptor 1-Induced Mechano-Hypersensitivities. Cell Mol Neurobiol 2021. [PMID: 34773542 DOI: 10.1007/s10571-021-01162-8] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
6 Wuerch E, Lozinski B, Yong VW. MedXercise: a promising strategy to promote remyelination. Curr Opin Pharmacol 2021;61:120-6. [PMID: 34688996 DOI: 10.1016/j.coph.2021.09.006] [Reference Citation Analysis]
7 Yousuf A, Qurashi A. Non-coding RNAs in the Pathogenesis of Multiple Sclerosis. Front Genet 2021;12:717922. [PMID: 34659340 DOI: 10.3389/fgene.2021.717922] [Reference Citation Analysis]
8 Nemeth DP, Quan N. Modulation of Neural Networks by Interleukin-1. Brain Plast 2021;7:17-32. [PMID: 34631418 DOI: 10.3233/BPL-200109] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
9 Rajendran R, Rajendran V, Giraldo-Velasquez M, Megalofonou FF, Gurski F, Stadelmann C, Karnati S, Berghoff M. Oligodendrocyte-Specific Deletion of FGFR1 Reduces Cerebellar Inflammation and Neurodegeneration in MOG35-55-Induced EAE. Int J Mol Sci 2021;22:9495. [PMID: 34502405 DOI: 10.3390/ijms22179495] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
10 Psenicka MW, Smith BC, Tinkey RA, Williams JL. Connecting Neuroinflammation and Neurodegeneration in Multiple Sclerosis: Are Oligodendrocyte Precursor Cells a Nexus of Disease? Front Cell Neurosci 2021;15:654284. [PMID: 34234647 DOI: 10.3389/fncel.2021.654284] [Cited by in Crossref: 10] [Cited by in F6Publishing: 13] [Article Influence: 10.0] [Reference Citation Analysis]
11 Tesser A, Pin A, Mencaroni E, Gulino V, Tommasini A. Vasculitis, Autoimmunity, and Cytokines: How the Immune System Can Harm the Brain. Int J Environ Res Public Health 2021;18:5585. [PMID: 34073717 DOI: 10.3390/ijerph18115585] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
12 Lu H, Wu PF, Zhang W, Liao X. Circulating Interleukins and Risk of Multiple Sclerosis: A Mendelian Randomization Study. Front Immunol 2021;12:647588. [PMID: 33936066 DOI: 10.3389/fimmu.2021.647588] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 6.0] [Reference Citation Analysis]
13 Talebi M, Talebi M, Kakouri E, Farkhondeh T, Pourbagher-Shahri AM, Tarantilis PA, Samarghandian S. Tantalizing role of p53 molecular pathways and its coherent medications in neurodegenerative diseases. Int J Biol Macromol 2021;172:93-103. [PMID: 33440210 DOI: 10.1016/j.ijbiomac.2021.01.042] [Cited by in Crossref: 11] [Cited by in F6Publishing: 13] [Article Influence: 11.0] [Reference Citation Analysis]
14 Sánchez-Fernández A, Zandee S, Amo-Aparicio J, Charabati M, Prat A, Garlanda C, Eisenmesser EZ, Dinarello CA, López-Vales R. IL-37 exerts therapeutic effects in experimental autoimmune encephalomyelitis through the receptor complex IL-1R5/IL-1R8. Theranostics 2021;11:1-13. [PMID: 33391457 DOI: 10.7150/thno.47435] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 9.0] [Reference Citation Analysis]
15 Nociti V, Santoro M. What do we know about the role of lncRNAs in multiple sclerosis? Neural Regen Res 2021;16:1715-22. [PMID: 33510060 DOI: 10.4103/1673-5374.306061] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 7.0] [Reference Citation Analysis]
16 Malhotra S, Costa C, Eixarch H, Keller CW, Amman L, Martínez-Banaclocha H, Midaglia L, Sarró E, Machín-Díaz I, Villar LM, Triviño JC, Oliver-Martos B, Parladé LN, Calvo-Barreiro L, Matesanz F, Vandenbroeck K, Urcelay E, Martínez-Ginés ML, Tejeda-Velarde A, Fissolo N, Castilló J, Sanchez A, Robertson AAB, Clemente D, Prinz M, Pelegrin P, Lünemann JD, Espejo C, Montalban X, Comabella M. NLRP3 inflammasome as prognostic factor and therapeutic target in primary progressive multiple sclerosis patients. Brain 2020;143:1414-30. [PMID: 32282893 DOI: 10.1093/brain/awaa084] [Cited by in Crossref: 60] [Cited by in F6Publishing: 60] [Article Influence: 30.0] [Reference Citation Analysis]
17 Wang X, Li B, Liu L, Zhang L, Ma T, Guo L. Nicotinamide adenine dinucleotide treatment alleviates the symptoms of experimental autoimmune encephalomyelitis by activating autophagy and inhibiting the NLRP3 inflammasome. Int Immunopharmacol 2021;90:107092. [PMID: 33290962 DOI: 10.1016/j.intimp.2020.107092] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 5.0] [Reference Citation Analysis]
18 Fulton CDM, Beasley DWC, Bente DA, Dineley KT. Long-term, West Nile virus-induced neurological changes: A comparison of patients and rodent models. Brain Behav Immun Health 2020;7:100105. [PMID: 34589866 DOI: 10.1016/j.bbih.2020.100105] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
19 Bruno A, Dolcetti E, Rizzo FR, Fresegna D, Musella A, Gentile A, De Vito F, Caioli S, Guadalupi L, Bullitta S, Vanni V, Balletta S, Sanna K, Buttari F, Stampanoni Bassi M, Centonze D, Mandolesi G. Inflammation-Associated Synaptic Alterations as Shared Threads in Depression and Multiple Sclerosis. Front Cell Neurosci 2020;14:169. [PMID: 32655374 DOI: 10.3389/fncel.2020.00169] [Cited by in Crossref: 17] [Cited by in F6Publishing: 20] [Article Influence: 8.5] [Reference Citation Analysis]
20 Taghizadeh E, Taheri F, Samadian MM, Soudyab M, Abi A, Gheibi Hayat SM. Role of long non-coding RNAs (LncRNAs) in multiple sclerosis: a brief review. Neurol Sci. 2020;41:2443-2451. [PMID: 32350675 DOI: 10.1007/s10072-020-04425-2] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
21 Cardozo PL, de Lima IBQ, Maciel EMA, Silva NC, Dobransky T, Ribeiro FM. Synaptic Elimination in Neurological Disorders. Curr Neuropharmacol 2019;17:1071-95. [PMID: 31161981 DOI: 10.2174/1570159X17666190603170511] [Cited by in Crossref: 29] [Cited by in F6Publishing: 33] [Article Influence: 14.5] [Reference Citation Analysis]
22 Luo T, Yu Q, Zou H, Zhao H, Gu J, Yuan Y, Zhu J, Bian J, Liu Z. Role of poly (ADP-ribose) polymerase-1 in cadmium-induced cellular DNA damage and cell cycle arrest in rat renal tubular epithelial cell line NRK-52E. Environ Pollut 2020;261:114149. [PMID: 32078880 DOI: 10.1016/j.envpol.2020.114149] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 6.0] [Reference Citation Analysis]
23 Khaw YM, Cunningham C, Tierney A, Sivaguru M, Inoue M. Neutrophil-selective deletion of Cxcr2 protects against CNS neurodegeneration in a mouse model of multiple sclerosis. J Neuroinflammation 2020;17:49. [PMID: 32019585 DOI: 10.1186/s12974-020-1730-y] [Cited by in Crossref: 13] [Cited by in F6Publishing: 15] [Article Influence: 6.5] [Reference Citation Analysis]
24 Ha ZY, Mathew S, Yeong KY. Butyrylcholinesterase: A Multifaceted Pharmacological Target and Tool. CPPS 2020;21:99-109. [DOI: 10.2174/1389203720666191107094949] [Cited by in Crossref: 22] [Cited by in F6Publishing: 24] [Article Influence: 11.0] [Reference Citation Analysis]
25 Williams JL, Manivasagam S, Smith BC, Sim J, Vollmer LL, Daniels BP, Russell JH, Klein RS. Astrocyte-T cell crosstalk regulates region-specific neuroinflammation. Glia 2020;68:1361-74. [PMID: 31961459 DOI: 10.1002/glia.23783] [Cited by in Crossref: 22] [Cited by in F6Publishing: 25] [Article Influence: 11.0] [Reference Citation Analysis]
26 Musella A, Fresegna D, Rizzo FR, Gentile A, De Vito F, Caioli S, Guadalupi L, Bruno A, Dolcetti E, Buttari F, Bullitta S, Vanni V, Centonze D, Mandolesi G. 'Prototypical' proinflammatory cytokine (IL-1) in multiple sclerosis: role in pathogenesis and therapeutic targeting. Expert Opin Ther Targets 2020;24:37-46. [PMID: 31899994 DOI: 10.1080/14728222.2020.1709823] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 4.5] [Reference Citation Analysis]
27 Klein JP, Sun Z, Staff NP. Association between ALS and retroviruses: evidence from bioinformatics analysis. BMC Bioinformatics 2019;20:680. [PMID: 31861978 DOI: 10.1186/s12859-019-3249-8] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
28 Saliba SW, Bonifacino T, Serchov T, Bonanno G, de Oliveira ACP, Fiebich BL. Neuroprotective Effect of AM404 Against NMDA-Induced Hippocampal Excitotoxicity. Front Cell Neurosci 2019;13:566. [PMID: 31920563 DOI: 10.3389/fncel.2019.00566] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
29 Ebrahimkhani S, Beadnall HN, Wang C, Suter CM, Barnett MH, Buckland ME, Vafaee F. Serum Exosome MicroRNAs Predict Multiple Sclerosis Disease Activity after Fingolimod Treatment. Mol Neurobiol 2020;57:1245-58. [PMID: 31721043 DOI: 10.1007/s12035-019-01792-6] [Cited by in Crossref: 20] [Cited by in F6Publishing: 21] [Article Influence: 6.7] [Reference Citation Analysis]
30 Sánchez-Fernández A, Skouras DB, Dinarello CA, López-Vales R. OLT1177 (Dapansutrile), a Selective NLRP3 Inflammasome Inhibitor, Ameliorates Experimental Autoimmune Encephalomyelitis Pathogenesis. Front Immunol 2019;10:2578. [PMID: 31736980 DOI: 10.3389/fimmu.2019.02578] [Cited by in Crossref: 38] [Cited by in F6Publishing: 40] [Article Influence: 12.7] [Reference Citation Analysis]
31 Feng X, Bao R, Li L, Deisenhammer F, Arnason BGW, Reder AT. Interferon-β corrects massive gene dysregulation in multiple sclerosis: Short-term and long-term effects on immune regulation and neuroprotection. EBioMedicine 2019;49:269-83. [PMID: 31648992 DOI: 10.1016/j.ebiom.2019.09.059] [Cited by in Crossref: 26] [Cited by in F6Publishing: 27] [Article Influence: 8.7] [Reference Citation Analysis]
32 Eissa N, Hussein H, Diarra A, Elgazzar O, Gounni AS, Bernstein CN, Ghia JE. Semaphorin 3E regulates apoptosis in the intestinal epithelium during the development of colitis. Biochem Pharmacol 2019;166:264-73. [PMID: 31170375 DOI: 10.1016/j.bcp.2019.05.029] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 4.0] [Reference Citation Analysis]
33 Tüzün E. Immunopathological Factors Associated with Disability in Multiple Sclerosis. Noro Psikiyatr Ars 2018;55:S26-30. [PMID: 30692851 DOI: 10.29399/npa.23303] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
34 Çomaklı S, Sevim Ç, Kontadakis G, Doğan E, Taghizadehghalehjoughi A, Özkaraca M, Aschner M, Nikolouzakis TK, Tsatsakis A. Acute glufosinate-based herbicide treatment in rats leads to increased ocular interleukin-1β and c-Fos protein levels, as well as intraocular pressure. Toxicol Rep 2019;6:155-60. [PMID: 30723690 DOI: 10.1016/j.toxrep.2019.01.004] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.7] [Reference Citation Analysis]
35 Sánchez-López AL, Ortiz GG, Pacheco-Moises FP, Mireles-Ramírez MA, Bitzer-Quintero OK, Delgado-Lara DLC, Ramírez-Jirano LJ, Velázquez-Brizuela IE. Efficacy of Melatonin on Serum Pro-inflammatory Cytokines and Oxidative Stress Markers in Relapsing Remitting Multiple Sclerosis. Arch Med Res 2018;49:391-8. [PMID: 30595364 DOI: 10.1016/j.arcmed.2018.12.004] [Cited by in Crossref: 44] [Cited by in F6Publishing: 39] [Article Influence: 11.0] [Reference Citation Analysis]
36 Dong Y, Pu K, Duan W, Chen H, Chen L, Wang Y. Involvement of Akt/CREB signaling pathways in the protective effect of EPA against interleukin-1β-induced cytotoxicity and BDNF down-regulation in cultured rat hippocampal neurons. BMC Neurosci 2018;19:52. [PMID: 30189852 DOI: 10.1186/s12868-018-0455-7] [Cited by in Crossref: 27] [Cited by in F6Publishing: 29] [Article Influence: 6.8] [Reference Citation Analysis]
37 Fenoglio C, Oldoni E, Serpente M, De Riz MA, Arcaro M, D'Anca M, Pietroboni AM, Calvi A, Lecchi E, Goris A, Mallants K, Dubois B, Comi C, Cantello R, Scarpini E, Galimberti D. LncRNAs expression profile in peripheral blood mononuclear cells from multiple sclerosis patients. J Neuroimmunol 2018;324:129-35. [PMID: 30170791 DOI: 10.1016/j.jneuroim.2018.08.008] [Cited by in Crossref: 21] [Cited by in F6Publishing: 23] [Article Influence: 5.3] [Reference Citation Analysis]
38 You R, Ho YS, Hung CH, Liu Y, Huang CX, Chan HN, Ho SL, Lui SY, Li HW, Chang RC. Silica nanoparticles induce neurodegeneration-like changes in behavior, neuropathology, and affect synapse through MAPK activation. Part Fibre Toxicol 2018;15:28. [PMID: 29970116 DOI: 10.1186/s12989-018-0263-3] [Cited by in Crossref: 48] [Cited by in F6Publishing: 51] [Article Influence: 12.0] [Reference Citation Analysis]
39 Wong CH, Gan SY, Tan SC, Gany SA, Ying T, Gray AI, Igoli J, Chan EWL, Phang SM. Fucosterol inhibits the cholinesterase activities and reduces the release of pro-inflammatory mediators in lipopolysaccharide and amyloid-induced microglial cells. J Appl Phycol 2018;30:3261-70. [DOI: 10.1007/s10811-018-1495-1] [Cited by in Crossref: 15] [Cited by in F6Publishing: 16] [Article Influence: 3.8] [Reference Citation Analysis]
40 Pozzi D, Menna E, Canzi A, Desiato G, Mantovani C, Matteoli M. The Communication Between the Immune and Nervous Systems: The Role of IL-1β in Synaptopathies. Front Mol Neurosci 2018;11:111. [PMID: 29674955 DOI: 10.3389/fnmol.2018.00111] [Cited by in Crossref: 31] [Cited by in F6Publishing: 31] [Article Influence: 7.8] [Reference Citation Analysis]
41 Singh S, Jha S. NLRs as Helpline in the Brain: Mechanisms and Therapeutic Implications. Mol Neurobiol 2018;55:8154-78. [DOI: 10.1007/s12035-018-0957-4] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
42 Barclay W, Shinohara ML. Inflammasome activation in multiple sclerosis and experimental autoimmune encephalomyelitis (EAE). Brain Pathol 2017;27:213-9. [PMID: 27997058 DOI: 10.1111/bpa.12477] [Cited by in Crossref: 85] [Cited by in F6Publishing: 88] [Article Influence: 21.3] [Reference Citation Analysis]
43 Silva BA, Leal MC, Farías MI, Avalos JC, Besada CH, Pitossi FJ, Ferrari CC. A new focal model resembling features of cortical pathology of the progressive forms of multiple sclerosis: Influence of innate immunity. Brain, Behavior, and Immunity 2018;69:515-31. [DOI: 10.1016/j.bbi.2018.01.010] [Cited by in Crossref: 23] [Cited by in F6Publishing: 24] [Article Influence: 5.8] [Reference Citation Analysis]
44 Morris G, Reiche EMV, Murru A, Carvalho AF, Maes M, Berk M, Puri BK. Multiple Immune-Inflammatory and Oxidative and Nitrosative Stress Pathways Explain the Frequent Presence of Depression in Multiple Sclerosis. Mol Neurobiol 2018;55:6282-306. [PMID: 29294244 DOI: 10.1007/s12035-017-0843-5] [Cited by in Crossref: 36] [Cited by in F6Publishing: 38] [Article Influence: 9.0] [Reference Citation Analysis]
45 Dehghanian F, Nabavizadeh N, Kamali E, Moeinifar N, Motovali-bashi M. A Complete Review on Epigenetic Biomarkers in MS. Neuroinflammation 2018. [DOI: 10.1016/b978-0-12-811709-5.00039-9] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
46 Morris G, Walder K, Carvalho AF, Tye SJ, Lucas K, Berk M, Maes M. The role of hypernitrosylation in the pathogenesis and pathophysiology of neuroprogressive diseases. Neurosci Biobehav Rev 2018;84:453-69. [PMID: 28789902 DOI: 10.1016/j.neubiorev.2017.07.017] [Cited by in Crossref: 23] [Cited by in F6Publishing: 24] [Article Influence: 4.6] [Reference Citation Analysis]
47 Szybińska A, Leśniak W. P53 Dysfunction in Neurodegenerative Diseases - The Cause or Effect of Pathological Changes? Aging Dis 2017;8:506-18. [PMID: 28840063 DOI: 10.14336/AD.2016.1120] [Cited by in Crossref: 61] [Cited by in F6Publishing: 61] [Article Influence: 12.2] [Reference Citation Analysis]
48 Mendiola AS, Cardona AE. The IL-1β phenomena in neuroinflammatory diseases. J Neural Transm (Vienna) 2018;125:781-95. [PMID: 28534174 DOI: 10.1007/s00702-017-1732-9] [Cited by in Crossref: 72] [Cited by in F6Publishing: 66] [Article Influence: 14.4] [Reference Citation Analysis]
49 Kong WL, Peng YY, Peng BW. Modulation of neuroinflammation: Role and therapeutic potential of TRPV1 in the neuro-immune axis. Brain Behav Immun 2017;64:354-66. [PMID: 28342781 DOI: 10.1016/j.bbi.2017.03.007] [Cited by in Crossref: 53] [Cited by in F6Publishing: 48] [Article Influence: 10.6] [Reference Citation Analysis]
50 Mamoudjy N, Maurey H, Marie I, Koné-Paut I, Deiva K. Neurological outcome of patients with cryopyrin-associated periodic syndrome (CAPS). Orphanet J Rare Dis 2017;12:33. [PMID: 28196516 DOI: 10.1186/s13023-017-0589-1] [Cited by in Crossref: 26] [Cited by in F6Publishing: 26] [Article Influence: 5.2] [Reference Citation Analysis]
51 Gentile A, Fresegna D, Musella A, Sepman H, Bullitta S, De Vito F, Fantozzi R, Usiello A, Maccarrone M, Mercuri NB, Lutz B, Mandolesi G, Centonze D. Interaction between interleukin-1β and type-1 cannabinoid receptor is involved in anxiety-like behavior in experimental autoimmune encephalomyelitis. J Neuroinflammation 2016;13:231. [PMID: 27589957 DOI: 10.1186/s12974-016-0682-8] [Cited by in Crossref: 27] [Cited by in F6Publishing: 28] [Article Influence: 4.5] [Reference Citation Analysis]
52 Burm SM, Peferoen LA, Zuiderwijk-Sick EA, Haanstra KG, 't Hart BA, van der Valk P, Amor S, Bauer J, Bajramovic JJ. Expression of IL-1β in rhesus EAE and MS lesions is mainly induced in the CNS itself. J Neuroinflammation 2016;13:138. [PMID: 27266875 DOI: 10.1186/s12974-016-0605-8] [Cited by in Crossref: 47] [Cited by in F6Publishing: 47] [Article Influence: 7.8] [Reference Citation Analysis]
53 Santoro M, Nociti V, Lucchini M, De Fino C, Losavio FA, Mirabella M. Expression Profile of Long Non-Coding RNAs in Serum of Patients with Multiple Sclerosis. J Mol Neurosci 2016;59:18-23. [PMID: 27034068 DOI: 10.1007/s12031-016-0741-8] [Cited by in Crossref: 76] [Cited by in F6Publishing: 68] [Article Influence: 12.7] [Reference Citation Analysis]
54 Zheng H, Liu CC, Atagi Y, Chen XF, Jia L, Yang L, He W, Zhang X, Kang SS, Rosenberry TL, Fryer JD, Zhang YW, Xu H, Bu G. Opposing roles of the triggering receptor expressed on myeloid cells 2 and triggering receptor expressed on myeloid cells-like transcript 2 in microglia activation. Neurobiol Aging 2016;42:132-41. [PMID: 27143430 DOI: 10.1016/j.neurobiolaging.2016.03.004] [Cited by in Crossref: 65] [Cited by in F6Publishing: 68] [Article Influence: 10.8] [Reference Citation Analysis]
55 Kimura-Ohba S, Yang Y. Oxidative DNA Damage Mediated by Intranuclear MMP Activity Is Associated with Neuronal Apoptosis in Ischemic Stroke. Oxid Med Cell Longev 2016;2016:6927328. [PMID: 26925194 DOI: 10.1155/2016/6927328] [Cited by in Crossref: 28] [Cited by in F6Publishing: 31] [Article Influence: 4.7] [Reference Citation Analysis]
56 Lieberknecht V, Junqueira SC, Cunha MP, Barbosa TA, de Souza LF, Coelho IS, Santos AR, Rodrigues AL, Dafré AL, Dutra RC. Pramipexole, a Dopamine D2/D3 Receptor-Preferring Agonist, Prevents Experimental Autoimmune Encephalomyelitis Development in Mice. Mol Neurobiol 2017;54:1033-45. [PMID: 26801190 DOI: 10.1007/s12035-016-9717-5] [Cited by in Crossref: 38] [Cited by in F6Publishing: 34] [Article Influence: 6.3] [Reference Citation Analysis]
57 Ruseva MM, Ramaglia V, Morgan BP, Harris CL. An anticomplement agent that homes to the damaged brain and promotes recovery after traumatic brain injury in mice. Proc Natl Acad Sci U S A 2015;112:14319-24. [PMID: 26578778 DOI: 10.1073/pnas.1513698112] [Cited by in Crossref: 55] [Cited by in F6Publishing: 61] [Article Influence: 7.9] [Reference Citation Analysis]
58 Berjaoui S, Povedano M, Garcia-Esparcia P, Carmona M, Aso E, Ferrer I. Complex Inflammation mRNA-Related Response in ALS Is Region Dependent. Neural Plast 2015;2015:573784. [PMID: 26301107 DOI: 10.1155/2015/573784] [Cited by in Crossref: 18] [Cited by in F6Publishing: 20] [Article Influence: 2.6] [Reference Citation Analysis]
59 Singh S, Jamwal S, Kumar P. Piperine Enhances the Protective Effect of Curcumin Against 3-NP Induced Neurotoxicity: Possible Neurotransmitters Modulation Mechanism. Neurochem Res 2015;40:1758-66. [DOI: 10.1007/s11064-015-1658-2] [Cited by in Crossref: 37] [Cited by in F6Publishing: 33] [Article Influence: 5.3] [Reference Citation Analysis]